Skip to main content

Table 1 METTL14 expression associated with clinical pathological variables (logistic regression)

From: Decreased expression of METTL14 predicts poor prognosis and construction of a prognostic signature for clear cell renal cell carcinoma

Variable METTL14 mRNA expression
OR 95% CI p
Age(year)
 > 65 vs. ≤ 65 0.769 0.532–1.110 0.161
Gender
 Female vs. male 0.573 0.395–0.827 0.003
Race
 African vs. White 0.923 0.198- 4.300 0.916
 Asian vs. White 0.915 0.507–1.644 0.766
Grade
 G3–4 vs. G1–2 0.338 0.235–0.484 0.000
Stage
 Stage III & IV VS Stage I & II 0.310 0.213–0.449 0.000
T stage
 T3–4 vs. T1–2 0.318 0.216–0.464 0.000
N stage
 N1-X vs. NO 0.867 0.611–1.229 0.423
M stage
 M1-X vs. M0 0.467 0.297–0.725 0.000